Related Experiment Video
Updated: Jul 9, 2026
07:06
Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
Published on: December 8, 2014
A case of clofazimine enteropathy
A Hameed1, F X Beach, R H Kennedy
1Yeovil District Hospital, Somerset, UK.
International Journal of Clinical Practice
|January 23, 1999
Summary
This case report details clofazimine enteropathy in a young male. Long-term clofazimine use led to severe gastrointestinal issues, pigment deposition, and fatal complications.
Area of Science:
- Gastroenterology
- Pharmacology
- Clinical Medicine
Background:
- Clofazimine is an antibiotic used in treating leprosy and other mycobacterial infections.
- Long-term administration of clofazimine can lead to various side effects.
- Enteropathy is a recognized, though infrequent, complication of clofazimine therapy.
Observation:
- A young male patient presented with a pigmented, emaciated state after four years of daily clofazimine (200 mg).
- Symptoms included abdominal pain, diarrhea, and significant weight loss.
- Laparotomy revealed dark brown-black pigment deposition in abdominal organs due to clofazimine crystal infiltration.
Findings:
- Despite clofazimine withdrawal, the patient's gastrointestinal symptoms persisted.
- The patient developed edema and hypoalbuminemia, indicating severe malnutrition and systemic effects.
- A fatal cerebral infarction occurred, potentially linked to the prolonged clofazimine toxicity.
Implications:
- This case highlights the potential for severe, irreversible clofazimine enteropathy with prolonged use.
- It underscores the importance of monitoring for gastrointestinal and systemic side effects during long-term clofazimine treatment.
- Further research into managing clofazimine-induced enteropathy and its long-term consequences is warranted.
Related Concept Videos
01:17Drugs for Treatment of Diarrhea-Predominant IBS
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
01:28Fungal Phylum Microsporidia
Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
01:18Bacterial Gastroenteritis
Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
01:27Cryptococcal Meningitis
Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
01:12Giardiasis
Giardiasis is a globally prevalent intestinal infection caused by the protozoan parasite Giardia duodenalis (also known as G. lamblia or G. intestinalis). This flagellated protozoan is the most frequently identified intestinal parasite in the United States and worldwide. Transmission primarily occurs via the fecal-oral route, with infection arising from ingestion of water or food contaminated with cysts. Individuals in low-resource settings, international travelers, outdoor enthusiasts, daycare...
01:28Amebiasis
Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...